Stocks of Elevance Health - Current price, Where to buy? Dividends
Detail | Data |
---|---|
Stocks: | Elevance Health |
ompany Name: | Elevance Health, Inc. |
Ticker: | ELV |
Exchange: | NYSE |
Outstanding stocks: | 232,418,000 |
24-hour Volume: | 179,607 |
Industry: | Healthcare Plans |
Sector: | Healthcare |
Number of Employees: | 104900 |
Country: | United States |
City: | Indianapolis |
Address: | 220 Virginia Avenue |
P/E Ratio: | Forward P/E | EPS: | Forward EPS | Book value per share | Market capitalization |
---|---|---|---|---|---|
20.20 | 12.28 | 25.24 USD | 41.54 USD | 168.64 USD | 125,431,341,056.00 USD |
P/E Ratio: | 20.20 |
---|---|
Forward P/E: | 12.28 |
EPS: | 25.24 USD |
Forward EPS: | 41.54 |
Book value per share: | 168.64 USD |
Market capitalization: | 125,431,341,056.00 USD |
Elevance Health
Fundamental Indicators
Indicator | Data |
---|---|
Total Revenue: | 171,340,005,376.00 USD |
Net Income: | 5,986,999,808.00 USD |
Price-to-Book (P/B) Ratio: | 3.02 |
PEG Ratio: | 1.16 |
Note: The data is approximate, subject to change over time, and may not be current; however, we strive for the highest possible accuracy.
Analysts' predictions
Analysts | Recommendation |
---|---|
Issued Recommendation: | According to our data, the recommendation issued for Elevance Health stocks is: buy |
Number of Analysts: | 16 |
Highest Target Price: | 629 USD |
Lowest Target Price: | 537 USD |
Average Target Price: | 580 USD |
Note: The data is approximate. Recommendations and price forecasts for Elevance Health stocks based on analysts' ratings may change over time. Some recommendations may already be outdated and may not be accurate. We strongly advise against buying and selling stocks based on analysts' recommendations!
Dividend
Dividends | Value |
---|---|
Dividend Amount | Company Elevance Health pays a dividend of 6.52 USD per share. |
Annual Yield %: | 1.27 % |
Ex-dividend Date: | 2024-03-07 |
Average % Yield for 5 Years: | 1.13 % |
Payout Ratio: | 23.47 % |
Value of Last Dividend Paid: | 1.63 USD |
Date of Last Dividend: | 2024-03-07 |
The dividend is displayed for the entire calendar year, however, it is usually paid out quarterly in parts. Data may change!
Where to Buy Elevance Health Stocks?
If you're interested in investing in Elevance Health stocks and believe in their future growth, you can purchase them through stock brokers like XTB or eToro. To make buying easier, we've prepared a table with offers from these brokers, including quick purchase of Elevance Health stocks through mobile apps with client support. In this table, you can compare brokers offering real Elevance Health stocks. Brokers providing the option to buy real stocks (not CFDs) are identified by "Real Stocks" in the comparison table column.
Broker | Platforms | Regulation | Min. Deposit | Deposits / Withdrawals | CopyTrader | Real Stocks | Website Link |
---|---|---|---|---|---|---|---|
Proprietary platform, social network + CopyTrader™ | 100 USD | Bank transfer, credit cards, Skrill, PayPal, Neteller | Go to eToro | ||||
xStation, mobile version | 10 USD | Credit cards, Skrill, bank transfer | Go to XTB |
xStation, mobile version | Proprietary platform, social network + CopyTrader™ |
Go to XTB | Go to eToro |
More Information about Elevance Health (ELV)
Elevance Health consistently proves itself as a leader in its industry. Total revenues for the last 12 months exceed 171,340,005,376.00 USD, demonstrating its strong market position and ability to generate high revenues. With EBITDA reaching 10,949,000,192.00 USD, Elevance Health maintains a high level of efficiency and profitability. This highlights its ability to manage operational costs effectively. Debt-to-equity ratio of 0.66 suggests that Elevance Health has a healthy financial structure and effectively manages its debts. This is key to stable growth. Gross margin of 27.44% indicates room for Elevance Health to improve cost efficiency and competitiveness. Lower profit margin of 3.49% suggests opportunities for Elevance Health to increase efficiency and reduce costs.
Indicator | Value |
---|---|
Revenue, Debt, and Cash Flow | |
Company Revenue: | 171,340,005,376.00 USD |
EBITDA: | 10,949,000,192.00 USD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization. |
Earnings Per Share: | 25.24 USD |
Book Value Per Share: | 168.64 USD |
Total Cash: | 36,368,998,400.00 USD |
Total Cash per Share: | 156.31 USD |
Total Debt: | 25,969,000,448.00 USD |
Debt to Equity Ratio: | 0.66 |
Quick Ratio: | 1.30 |
Current Ratio: | 1.44 |
Free Cash Flow: | 3,004,875,008.00 USD |
Operating Cash Flow: | 8,061,000,192.00 USD |
Company Margins | |
Gross Margins: | 27.44 % |
EBITDA Margins: | 6.39 % |
Operating Margins: | 5.64 % |
Profit Margins: | 3.49 % |
Performance | |
Return on Assets: | 5.8 % |
Return on Equity: | 15.8 % |
Earnings Growth (1 year): | 1.2% |
Revenue Growth (1 year): | 6.8 % |
Year-over-Year Quarterly Earnings Growth: | -1.0 % |
Valuation | |
Market Capitalization: | 125,431,341,056.00 USD |
Enterprise Value: | 109,076,676,608.00 USD |
EV/Revenue: | 0.637 |
EV/EBITDA: | 9.962 |
Number of Shares and Short Shares | |
Float Shares: | 232,045,183 shares |
Shares Outstanding: | 232,668,992 shares |
Held Percent Insiders: | 0.00 % |
Held Percent Institutions: | 92.08 % |
Shares Short: | 1,714,896 |
Shares Short Prior Month: | 2,113,748 |
Date Short Interest: | 2024-02-29 |
Shares Percent Shares Out: | 0.74 % |
Short Ratio: | 1.93 |
Beta: | 0.78 |
Short Percent of Float: | 0.74 % |
Předpokládaný počet akcií: | 232,668,992 |
Frequently Asked Questions (FAQ)
The company Elevance Health pays a dividend of 6.52 USD per share. At this rate, the annual yield is 1.27 %.
Elevance Health shares are traded on the stock exchange NYSE under the ticker symbol: ELV. You can buy or trade them with a variety of stock brokers offering real stock trading services.
According to our data, there is a buy recommendation issued for Elevance Health shares by a total of 16 analysts. The average target price prediction is 580 USD per share.
The total number of Elevance Health shares on the exchange is 232,668,992.00, which, at the current market capitalization, values the company at 125,431,341,056.00 USD.